HYPEREOSINOPHILIC SYNDROME
Clinical trials for HYPEREOSINOPHILIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HYPEREOSINOPHILIC SYNDROME trials appear
Sign up with your email to follow new studies for HYPEREOSINOPHILIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame rare blood disorder flares
Disease control OngoingThis study is testing whether a drug called benralizumab, given as an injection every 4 weeks, can help control Hypereosinophilic Syndrome (HES). HES is a rare disorder where high levels of white blood cells cause inflammation and damage to organs. The trial will see if the drug …
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Cancer drug trial offers hope for rare blood disease
Disease control OngoingThis study is testing whether a drug called imatinib (Gleevec®), which is used for some cancers, can safely and effectively lower dangerously high levels of a specific white blood cell (eosinophils) in people with hypereosinophilic syndrome (HES). HES is a rare condition where to…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC